Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H38O5S |
Molecular Weight | 462.642 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(=O)CSC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)CC[C@]34C
InChI
InChIKey=BISFDZNIUZIKJD-XDANTLIUSA-N
InChI=1S/C26H38O5S/c1-23(2,3)22(30)32-14-20(29)26(31)11-9-18-17-7-6-15-12-16(27)8-10-24(15,4)21(17)19(28)13-25(18,26)5/h12,17-19,21,28,31H,6-11,13-14H2,1-5H3/t17-,18-,19-,21+,24-,25-,26-/m0/s1
Molecular Formula | C26H38O5S |
Molecular Weight | 462.642 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tixocortol is a synthetic steroid with topical anti-inflammatory properties. In form of Tixocortol pivalate, also known as Pivalone, it is used to treat the inflammatory and allergic manifestations of the rhino-pharynx: allergic rhinitis, acute and chronic congestive rhinitis, vasomotor rhinitis. In addition, it has been shown to be a useful agent for assessing corticosteroid contact dermatitis, particularly for hydrocortisone-type derivatives. Labeled adverse effects are: itchy nose, dryness of the nasal mucosa, edema of the face mucosa, cataract, glaucoma, Cushing syndrome, skin thinning.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:32 GMT 2023
by
admin
on
Fri Dec 15 15:01:32 GMT 2023
|
Record UNII |
6K28E35M3B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
||
|
NCI_THESAURUS |
C211
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
TIXOCORTOL PIVALATE
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107112
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
C152668
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
63564
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
SUB04894MIG
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
55560-96-8
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
DTXSID30970904
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
15052414
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
6K28E35M3B
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
6K28E35M3B
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
DBSALT001131
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
Y-58
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
38336
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000091288
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
259-706-4
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
C019112
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
m10911
Created by
admin on Fri Dec 15 15:01:32 GMT 2023 , Edited by admin on Fri Dec 15 15:01:32 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |